from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3541c/-

LFCtreatmentdescriptionclass of inhibitor

-0.887

Amikacinug/mL Amikacintranslation

-0.708

Cap5-10ug/mL Capreomycintranslation

-0.694

Rox10-50 ug/mL Roxithromycintranslation

0.090

SM2-5 ug/mL Streptomycintranslation

-1.652

Tet5-10 ug/mL Tetracyclinetranslation

-0.263

Rif0.2-5ug/mL Rifampicintranscription

-0.466

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.268

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.302

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.077

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.575

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.494

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.204

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.006

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.347

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.003

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.039

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.562

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.018

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.062

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.233

KCN5-20 ug/mL Potassium cyaniderespiration

-0.735

NaN30.2-2 mM Sodium aziderespiration

0.033

Nigericin50 uM Nigericinrespiration

0.164

TRC10-150 ug/mL Triclosanrespiration

-1.391

TRZ10-25 ug/mL Thioridazinerespiration

0.902

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.328

menadione6-10 ug/mL Menadionerespiration

2.066

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.218

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.018

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.003

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.924

NRP_1Non-replicating persistence stage 1dosRassociated

0.284

Amp0.2mg/mL AmpicillincellWall

-0.197

Cephalexin20-100 ug/mL CephalexincellWall

-0.061

Cerulenin0.32-5 ug/mL CerulenincellWall

0.950

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.249

EMB10-20 ug/mL EthambutolcellWall

0.051

Eta12-40 ug/mL EthionamidecellWall

0.207

INH0.2-0.4 ug/mL IsoniazidcellWall

0.179

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.468

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.271

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.041

BZA0.12 mg/mL BenzamidearomaticAmides

-0.492

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.199

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.240

H2O24 mM hydrogen peroxideDNAdamaging

0.262

Levo10 ug/mL LevofloxacinDNAdamaging

-0.181

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.766

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.591

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.179

UVUV-irradiationDNAdamaging

-1.008

ARP41-4 ug/mL Antitubercular compound ARP4?

0.250

Antimycin12.5-50 ug/mL Antimycin A?

-0.178

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.492

PA_110-50 ug/mL Antitubercular compound PA-1?

0.589

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.185

PA8240.2-2 ug/mL PA-824?

1.529

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.629

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.381

Verapamil50 uM Verapamil?

-0.381

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.051

methoxatin10-20 ug/mL Methoxatin?